There is a growing body of evidence supporting the vastapplicability and superiority of treatment outcomes of stem cell therapies,compared to conventional treatment options. In fact, the unmet needs withinthis domain have spurred the establishment of many start-ups in recent years. Further,recent studies suggest that mesenchymal stem cells mesenchymal stem cells canbe effectively used to improve patients' resistance to the SARS-CoV-2 virusinduced pneumonia leading to speedy recovery.
To order this 500+ page report, which features 185+ figuresand 220+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/stem-cells-market/296.html
The USD 8.5 billion (by 2030) financial opportunitywithin the stem cell therapies market has been analyzed across the followingsegments:
§ Sourceof stem cell
§ Allogeneic
§ Autologous
§ Originof stem cell
§ Adult
§ Embryonic
§ Type of stem cell
§ Hematopoietic
§ Mesenchymal
§ Progenitor
§ Others
§ Lineageof stem cell
§ AdiposeTissue
§ BoneMarrow
§ CordBlood
§ Others
§ Routeof Administration
§ Intraarticular
§ Intracoronary
§ Intramuscular
§ Intramyocardial
§ Intrathecal
§ Intravenous
§ SurgicalImplantations
§ Others
§ TherapeuticArea
§ Autoimmune/ Inflammatory Disorder
§ CardiovascularDisorders
§ MetabolicDisorder
§ MusculoskeletalDisorders
§ OncologicalDisorders
§ NeurologicalDisorders
§ OphthalmicDisorders
§ Others
§ EndUsers
§ AmbulatorySurgery Centers
§ Hospitals
§ SpecialtyClinics
§ KeyGeographies
§ NorthAmerica
§ Europe
§ Asia-Pacificand Rest of the World
The Global Stem CellsMarket:Focus on Clinical Therapies, 2020–2030 (Based on Source (Allogeneic,Autologous); Origin (Adult, Embryonic); Type (Hematopoietic, Mesenchymal,Progenitor); Lineage (Amniotic Fluid, Adipose Tissue, Bone Marrow,Cardiosphere, Chondrocytes, Corneal Tissue, Cord Blood, Dental Pulp, NeuralTissue Placenta, Peripheral Blood, Stromal Cells); and Potency (Multipotent,Pluripotent))”. report features thefollowing companies, which we identified to be key players in this domain:
§ Anterogen
§ Athersys
§ CHABiotech
§ Cytopeutics
§ Hope Biosciences
§ Japan Regenerative Medicine
§ Lineage Cell Therapeutics
§ Orchard Therapeutics
§ Osiris Therapeutics
§ Pluristem Therapeutics
§ Promithera Biosciences
§ Regenexx
§ Stempeutics Research
§ SCM Life Sciences
§ TICEBA
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Market Landscape
5. Company Profiles
6. Key Therapeutic Areas
7. Assessment of Relative Competition and GrowthOpportunities
8. Academic Grants Analysis
9. Clinical Trail Analysis
10. Stem Cell Manufacturing Market Landscape and KPIsfor Evaluating Contract
Services Partners
11. Stem Cell Therapy Developers and CMOs: OpportunityAssessment
12. Key Commercialization Strategies
13. Market Forecast
14. Conclusion
15. Executive Insights
16. Appendix 1: Tabulated Data
17. Appendix 2: List of Companies and Organizations
To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/stem-cells-market/296.html/
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
